Transforming Human
Health & Aging
Using worms.

Hung is the VP of Preclinical Development at Holoclara. He brings more than 28 years of drug development expertise from research to clinic, including 18 years at Amgen. He received his PhD from the University of Pennsylvania.

Oliver brings a diverse range of leadership skills to Holoclara, having previously overseen IP, licensing, and entrepreneurship at Caltech’s Office of Technology Transfer. He also managed R&D and business operations at 1200 Pharma, where he was part of the founding team.

Mariana received her PhD at USC, where her doctoral work focused on innate immune tolerance. Mari brings her immunology leadership expertise to Holoclara, with previous experience building and leading an R&D team in autoimmune therapy.

Nick is a Scientist at Holoclara with a focus on computational biology. He completed his postdoctoral work at UC Berkeley, using single cell transcriptomics to characterize novel interactions during organogenesis and tissue regeneration. He received his PhD at UC Berkeley.

Winnie is a Senior Research Associate at Holoclara, with a focus on in vivo and in vitro immunology assay development. She brings more than 20 years of experience in the life science industry. She received her BS at UCLA.

Biola is a Research Associate at Holoclara. She received her Bachelors of Science from Chapman University, where her laboratory research focused on microbiology and immunology. Following her graduation, she worked at Zymo Research.

Sarah is the Executive Assistant to the CEO.  She has extensive experience in administration and lab management in the life science research space, which includes 17 years at Caltech and City of Hope.

Alan Levy is an experienced serial entrepreneur, having served as the CEO of five life science companies, as senior advisor for Frazier Healthcare, and as senior executive at J&J. He currently serves on the BOD of multiple private and public companies.

Peter B Hutt is a senior counsel at Covington & Burling LLP, where he specializes in Food and Drug Law. Peter is among the top health care lawyers and FDA regulatory specialists in the US. He received his Bachelor of Laws at Harvard and his Master of Laws at NYU.

Andrea Choe is the CEO and co-founder of Holoclara.

Neal Bhadkamkar is a General Partner at Bold Capital. He brings more than 30 years of investment and start-up experience. He has previously served as General Partner of Monitor Ventures and Head of Commercialization for the Paul Allen-backed incubator, Interval Research. He received his PhD from Stanford University and his MBA from Harvard.

Patrick Zhang is an investor at Horizons Ventures, where he leads biotechnology and healthcare investments. He has previously served as a financial advisor at Morgan Stanley. He received his BS in chemical engineering from UCLA and MBA from Columbia Business School.

Seemay Chou is the CEO and co-founder of Arcadia Sciences. Seemay previously held a position as Assistant Professor in Biochemistry and Biophysics at UCSF. Seemay is also co-founder and CEO of Trove Biolabs. She received a PhD in Molecular Cell Biology from UC Berkeley.